A Study of Denosumab in Multiple Myeloma Patients With Renal Insufficiency

PHASE2CompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

August 31, 2016

Primary Completion Date

March 20, 2023

Study Completion Date

March 20, 2023

Conditions
Multiple Myeloma
Interventions
DRUG

Denosumab Q4W

Trial Locations (7)

14642

University of Rochester Medical Center, Rochester

30322

Emory University Hospital, Atlanta

44106

University Hospitals of Cleveland, Cleveland

02114

Massachusetts general Hospital, Boston

02215

Dana-Farber Cancer Institute, Boston

01923

Mass General/North Shore Cancer Center, Danvers

02462

Newton Wellesley Hospital, Newton

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Amgen

INDUSTRY

collaborator

Emory University

OTHER

collaborator

University of Rochester

OTHER

collaborator

University Hospitals Cleveland Medical Center

OTHER

lead

Massachusetts General Hospital

OTHER